A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Corticotropin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Proof of concept; Therapeutic Use
- Acronyms PENNANT
- Sponsors Mallinckrodt LLC
- 22 Mar 2018 Planned End Date changed from 1 Mar 2020 to 1 Dec 2019.
- 22 Mar 2018 Planned primary completion date changed from 1 Mar 2020 to 1 Dec 2019.
- 22 Sep 2017 Planned End Date changed from 1 Nov 2020 to 1 Mar 2020.